Identification of the First SARS-CoV-2 Lineage B.1.1.529 Virus Detected in Europe.

Journal

Microbiology resource announcements
ISSN: 2576-098X
Titre abrégé: Microbiol Resour Announc
Pays: United States
ID NLM: 101728794

Informations de publication

Date de publication:
17 Feb 2022
Historique:
pubmed: 4 2 2022
medline: 4 2 2022
entrez: 3 2 2022
Statut: ppublish

Résumé

We report the complete genome sequence of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant (lineage B.1.1.529) from a Belgian patient with a history of recent travel to Egypt. At the time of writing, this genome constituted the first confirmed case of an infection with the Omicron variant in Europe.

Identifiants

DOI: 10.1128/mra.01161-21 PMID: 35112910 PMC: PMC8812313
pubmed: 35112910
doi: 10.1128/mra.01161-21
pmc: PMC8812313
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e0116121

Auteurs

Bert Vanmechelen (B)

KU Leuven, Department of Microbiology, Immunology, and Transplantation, Laboratory of Clinical and Epidemiological Virology, Rega Institute for Medical Research, Leuven, Belgium.
ORCID: 0000-0002-8350-4356

Anne-Sophie Logist (AS)

KU Leuven, Department of Microbiology, Immunology, and Transplantation, Laboratory of Clinical and Epidemiological Virology, Rega Institute for Medical Research, Leuven, Belgium.

Tony Wawina-Bokalanga (T)

KU Leuven, Department of Microbiology, Immunology, and Transplantation, Laboratory of Clinical and Epidemiological Virology, Rega Institute for Medical Research, Leuven, Belgium.

Jens Verlinden (J)

KU Leuven, Department of Microbiology, Immunology, and Transplantation, Laboratory of Clinical and Epidemiological Virology, Rega Institute for Medical Research, Leuven, Belgium.

Joan Martí-Carreras (J)

KU Leuven, Department of Microbiology, Immunology, and Transplantation, Laboratory of Clinical and Epidemiological Virology, Rega Institute for Medical Research, Leuven, Belgium.

Caspar Geenen (C)

KU Leuven, Department of Microbiology, Immunology, and Transplantation, Laboratory of Clinical Microbiology, National Reference Laboratories for COVID-19, Leuven, Belgium.

Bram Slechten (B)

KU Leuven, Department of Microbiology, Immunology, and Transplantation, Laboratory of Clinical Microbiology, National Reference Laboratories for COVID-19, Leuven, Belgium.

Lize Cuypers (L)

KU Leuven, Department of Microbiology, Immunology, and Transplantation, Laboratory of Clinical Microbiology, National Reference Laboratories for COVID-19, Leuven, Belgium.
UZ Leuven, Department of Laboratory Medicine, Leuven, Belgium.

Emmanuel André (E)

KU Leuven, Department of Microbiology, Immunology, and Transplantation, Laboratory of Clinical Microbiology, National Reference Laboratories for COVID-19, Leuven, Belgium.
UZ Leuven, Department of Laboratory Medicine, Leuven, Belgium.

Guy Baele (G)

KU Leuven, Department of Microbiology, Immunology, and Transplantation, Laboratory of Clinical and Epidemiological Virology, Rega Institute for Medical Research, Leuven, Belgium.

Piet Maes (P)

KU Leuven, Department of Microbiology, Immunology, and Transplantation, Laboratory of Clinical and Epidemiological Virology, Rega Institute for Medical Research, Leuven, Belgium.
ORCID: 0000-0002-4571-5232

Classifications MeSH